Connect With Us

Inside INdiana Business
Subscribe Now Log In
  • Home
  • News
    • Education
    • Health
    • Tech
    • STEM
    • Advanced Manufacturing & Logistics
    • Life Sciences
    • Ag INnovation
    • INPower
  • Videos
  • Big Wigs
    • Submit Big Wigs
  • Events
    • Engage Central Indiana – Indianapolis
    • Engage Northeast Indiana – Fort Wayne
    • Engage West Central Indiana – Terre Haute
    • Engage Greater Lafayette – West Lafayette
    • Engage Northwest Indiana – Valparaiso
    • Engage South Bend – Elkhart
    • Engage Southwest Indiana – Evansville
  • Newsletters
  • Podcasts
  • On-Air
    • TV & Radio Listings
  • Contact
    • About IIB
    • Meet the Team
    • Contact Us
    • Advertise
    • Gift Cards
    • Flagship Stations
    • Gerry’s Message
    • Speaking Engagement Request

Connect With Us

BASi Swings to Quarterly Loss

Thursday, May 16, 2019 03:37 PM EDT Updated: Friday, May 17, 2019 01:39 PM EDT
By Alex Brown
BASi Swings to Quarterly Loss

West Lafayette-based Bioanalytical Systems Inc. (Nasdaq: BASI) is reporting a fiscal second quarter net loss of $569,000, compared to net income of $66,000 during the same period last year. Despite the drop, the pharmaceutical development company saw a 60 percent increase in revenue for the quarter.

BASi says the revenue growth was driven largely by incremental sales associated with last year’s acquisition of Missouri-based Seventh Wave Laboratories LLC. However, the company’s net income was impacted by "the mix of revenues, recruiting and relocation of the management team and growing the employee base, and higher sales and marketing expenses."

Chief Executive Officer Robert Leasure says the results are in line with the company’s expectations for the fiscal year.

"This quarter we were able to recruit and fill open leadership and scientific team positions that are critical to meeting the future expectations of our clients, employees and shareholders," said Leasure. "We have continued the integration process of the Seventh Wave acquisition, and on May 1, 2019, completed the acquisition of Smithers Avanza’s toxicology facility in Gaithersburg, Maryland. The new building expansion and facility improvements in our Evansville facility continue to move forward. We obtained funding to support these initiatives and other improvements to our facilities and equipment to support future growth and enhance our scientific capabilities and client experiences. We are proud of the foundation we continue to build for the future."

You can connect to the full earnings report by clicking here.

Editor’s Note: A previous version of this story noted the net loss in millions, rather than thousands.

Story Continues Below

Most Popular Stories

Perspectives

Stop disease comeback stories with vaccinations

Stop disease comeback stories with vaccinations

While Americans typically love a good comeback story, there’s one taking place today that poses a growing – and preventable – threat to our communities and children: Childhood diseases are making a comeback as a result of a continued decline in childhood vaccination rates. ...

Inside INdiana Business

Inside INdiana Business
A division of IBJ Media

1 Monument Circle, Suite 300
Indianapolis, IN 46204

PHONE: (317) 634-6200

FAX: (317) 263-5060

NEWSLETTER@IIBNEWS.COM

  • Home
  • News
  • Videos
  • Gerry Dick
  • Newsletters
  • On-Air
  • Contact

Copyright © 2023 All Rights Reserved Privacy Policy | Terms of Service